Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02246543
Other study ID # 2/033/13
Secondary ID 132033
Status Completed
Phase N/A
First received September 15, 2014
Last updated March 23, 2016
Start date August 2013
Est. completion date October 2015

Study information

Verified date March 2016
Source University of Aberdeen
Contact n/a
Is FDA regulated No
Health authority United Kingdom: National Research Ethics Service
Study type Interventional

Clinical Trial Summary

This study will have the primary aim to investigate within-day changes in appetite after consumption of high-protein (HP, 30% of calories) and normal, or low, protein (LP, 15% of calories) whey protein meal, in solid and liquid form, on appetite and ad libitum food intake. Secondary objective will be to assess the statistical relationship between plasma concentrations of gut hormones and visual analogue scales (subjective hunger and fullness) and transit time.

In order to investigate the interaction of food structure and protein content on appetite, this requires, in practice, either a differing amount (g) or calorie (kJ) load as a function of energy density (defined as kJ/100g). Delivering the test meal as a solid and liquid form gives an easy solution to achieve this manipulation without compromising the nutritional profile. Following on from this decision, it is easier to produce different preloads using whey protein (rather than meat protein), since it is easily incorporated into test meals.


Description:

A randomized crossover design in 10 overweight/obese (BMI 26-40) men and 10 lean men (BMI 18.5-25). The control will be water. Each subject will attend the HNU on six separate occasions. The five test meal challenges will involve subjects attending the Human Nutrition Unit (HNU) in the morning, after an overnight fast. The total time of test meal visits will be approximately 4½hours. They will be provided with a standardised meal, after which blood samples will be collected for the first 2hrs. The following five treatments will be tested:

Treatment 1 Control - Water + Egg Yolk Mixture + 13C Octanoic Acid Treatment 2 HPL (High Protein Liquid): 30% protein; 30% fat and 40% carbohydrate (CHO) Treatment 3 LPL (Low Protein Liquid): 15% protein; 30% fat and 55% CHO Treatment 4 HPS (High Protein Solid): 30% protein; 30% fat and 40% CHO Treatment 5 LPS (Low Protein Solid): 15% protein; 30% fat and 55% CHO Test meals will be of fixed nutritional composition for all participants. The liquid meal will be a milk/fruit smoothie mixture and the 'solid' will be in a milk jelly (set) form.

Ad libitum pasta meal: 15% protein; 30% fat and 55% CHO as a homogenous mix and energy density of around 400kJ/100g - served in excess as a individual 600g portion to 'help-yourself'.

Subjective average appetite will be measured (every 30 min by visual analogue scales) over 4hr and ad libitum food intake will measured 4hr after treatment consumption. Ad libitum lunch will be a homogenous pasta meal with tomato sauce and a bottle of water. Blood samples will be collected every 10 min for the first half hour, every 15 min for the second half hour and every 30mins subsequently. The breath gastric emptying measurement will be assessed using the 13Carbon (13C) Octanoic Acid stable isotopic technique19. This involves mixing the tracer into food and taking breath samples and measured by isotope ratio mass spectrometry. 13C Octanoic acid is a medium chain fatty acid which is rapidly absorbed in the duodenum and metabolised in the liver. Following oxidation, the resulting Carbon Dioxide (CO2) is excreted into breath (12 samples will be collected during the 4hr test day).


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date October 2015
Est. primary completion date October 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 75 Years
Eligibility Inclusion Criteria:

- BMI = 18.5-40kg/m2

Exclusion Criteria:

- Diabetes

- Severe gastrointestinal disorders

- Kidney disease

- Thromboembolic or coagulation disease

- Hepatic disease

- Alcohol or any other substance abuse

- Gout

- Eating disorders

- Food allergy

- Unregulated thyroid disease

- Psychiatric disorders (including severe depression, lithium treatment, schizophrenia, severe behavioural disorders)

- Vegetarians & Vegans

Medication Exclusion Criteria:

- Orlistat (Xenical)

- Oral antidiabetics, insulin

- Rimonabant (Acomplia)

- Digoxin, anti-arrhythmics

- Sibutramine (Reductil)

- Tricyclic antidepressants, neuroleptics

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Control
Water, Toast & Egg (Yolk only) + 0.1g 13C Octanoic Acid
HPL
High Protein Smoothie (Liquid): 30% protein; 30% fat and 40% CHO + 0.1g 13C Octanoic Acid
LPL
Low Protein Smoothie (Liquid): 15% protein; 30% fat and 55% CHO + 0.1g 13C Octanoic Acid
HPS
High Protein Milk Jelly (Solid): 30% protein; 30% fat and 40% CHO + 0.1g 13C Octanoic Acid
LPS
Low Protein Milk Jelly (Solid): 15% protein; 30% fat and 55% CHO + 0.1g 13C Octanoic Acid

Locations

Country Name City State
United Kingdom Rowett Institute of Nutrition & Health, University of Aberdeen Aberdeen Aberdeen City

Sponsors (1)

Lead Sponsor Collaborator
University of Aberdeen

Country where clinical trial is conducted

United Kingdom, 

References & Publications (19)

Akhavan T, Luhovyy BL, Anderson GH. Effect of drinking compared with eating sugars or whey protein on short-term appetite and food intake. Int J Obes (Lond). 2011 Apr;35(4):562-9. doi: 10.1038/ijo.2010.163. Epub 2010 Aug 24. — View Citation

Anderson GH, Tecimer SN, Shah D, Zafar TA. Protein source, quantity, and time of consumption determine the effect of proteins on short-term food intake in young men. J Nutr. 2004 Nov;134(11):3011-5. — View Citation

Anderson GH. Much ado about high-fructose corn syrup in beverages: the meat of the matter. Am J Clin Nutr. 2007 Dec;86(6):1577-8. — View Citation

Bellissimo N, Desantadina MV, Pencharz PB, Berall GB, Thomas SG, Anderson GH. A comparison of short-term appetite and energy intakes in normal weight and obese boys following glucose and whey-protein drinks. Int J Obes (Lond). 2008 Feb;32(2):362-71. Epub 2007 Aug 14. — View Citation

Burton-Freeman BM. Glycomacropeptide (GMP) is not critical to whey-induced satiety, but may have a unique role in energy intake regulation through cholecystokinin (CCK). Physiol Behav. 2008 Jan 28;93(1-2):379-87. Epub 2007 Oct 26. — View Citation

DiMeglio DP, Mattes RD. Liquid versus solid carbohydrate: effects on food intake and body weight. Int J Obes Relat Metab Disord. 2000 Jun;24(6):794-800. — View Citation

Drewnowski A, Bellisle F. Liquid calories, sugar, and body weight. Am J Clin Nutr. 2007 Mar;85(3):651-61. Review. Erratum in: Am J Clin Nutr. 2007 Jun;85(6):1668. — View Citation

Gustafson DR, McMahon DJ, Morrey J, Nan R. Appetite is not influenced by a unique milk peptide: caseinomacropeptide (CMP). Appetite. 2001 Apr;36(2):157-63. — View Citation

Kissileff HR, Gruss LP, Thornton J, Jordan HA. The satiating efficiency of foods. Physiol Behav. 1984 Feb;32(2):319-32. — View Citation

Kissileff HR. Effects of physical state (liquid-solid) of foods on food intake: procedural and substantive contributions. Am J Clin Nutr. 1985 Nov;42(5 Suppl):956-65. — View Citation

Lacroix M, Mosora F, Pontus M, Lefebvre P, Luyckz A, Lopez-Habib G. Glucose naturally labeled with carbon-13: use for metabolic studies in man. Science. 1973 Aug 3;181(4098):445-6. — View Citation

Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet. 2001 Feb 17;357(9255):505-8. — View Citation

Luhovyy BL, Akhavan T, Anderson GH. Whey proteins in the regulation of food intake and satiety. J Am Coll Nutr. 2007 Dec;26(6):704S-12S. Review. — View Citation

Mattes RD. Beverages and positive energy balance: the menace is the medium. International Journal of Obesity 30: S60-S65, 2006.

Mourao DM, Bressan J, Campbell WW, Mattes RD. Effects of food form on appetite and energy intake in lean and obese young adults. Int J Obes (Lond). 2007 Nov;31(11):1688-95. Epub 2007 Jun 19. — View Citation

Rolls BJ, Fedoroff IC, Guthrie JF, Laster LJ. Foods with different satiating effects in humans. Appetite. 1990 Oct;15(2):115-26. — View Citation

Weigle DS, Breen PA, Matthys CC, Callahan HS, Meeuws KE, Burden VR, Purnell JQ. A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr. 2005 Jul;82(1):41-8. — View Citation

Westerterp-Plantenga MS, Lejeune MP, Nijs I, van Ooijen M, Kovacs EM. High protein intake sustains weight maintenance after body weight loss in humans. Int J Obes Relat Metab Disord. 2004 Jan;28(1):57-64. — View Citation

Wolf A, Bray GA, Popkin BM. A short history of beverages and how our body treats them. Obes Rev. 2008 Mar;9(2):151-64. doi: 10.1111/j.1467-789X.2007.00389.x. Review. — View Citation

* Note: There are 19 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Other Changes in subjective appetite using visual analogue scales Every 30mins, six appetite questions are answered
How hungry do you feel?
How full do you feel?
How strong is your desire to eat?
How much do you think you could eat now
How thirsty are you?
Preoccupation with thoughts of food?
On each test day the appetite questions are answered every 30mins during the 4hour visit. No
Other Ad libitum food intake To assess if each test breakfast provided has an influence on subsequent meals the consumption of the following are recorded:
- Ad libitum pasta meal: 15% protein; 30% fat and 55% CHO as a homogenous mix and energy density of around 400kJ/100g - served in excess at lunchtime as an individual 600g portion to 'help-yourself'.
Participants then record all additional meals & snacks consumed at home in a food diary
Recorded at T240mins on the test day visit and then for approximately 12hours at home. Therefore all food consumed during the 24hours of the test day will be assessed No
Primary Changes in postprandial biomarkers of satiety as measured by gut-related hormones The biomarkers to be measured on the Luminex system are Ghrelin (active), Glucagon-like peptide (GLP1), Peptide YY (PYY), Amylin, Leptin & Insulin
Biomarkers of Cardiovascular Disease (CVD) risk including total cholesterol, Low Density Lipoprotein Cholesterol (LDL), High Density Lipoprotein (HDL), triglycerides, nonesterified fatty acids (NEFA) will also be measured along with assessment of peripheral glycaemic control, fasting glucose, area under the curve combined with insulin data.
On each test day blood samples are collected every 10 min for the first half hour, every 15 min for the second half hour and every 30mins subsequently. (Eight samples are therefore collected for 2hours at T0, T10, T20, T30, T45, T60, T90 and T120mins) No
Secondary Changes in postprandial gastric emptying, measured using breath samples This is assessed using the 13C Octanoic Acid stable isotopic technique. A tracer is mixed into food and breath samples are collected which are analysed by isotope ratio mass spectrometry. 13C Octanoic acid is a medium chain fatty acid which is rapidly absorbed in the duodenum and metabolised in the liver. Following oxidation, the resulting CO2 is excreted into breath (12 samples will be collected during the 4hr test day). On each test day samples are collected every 15mins for the first 2½hrs then every 30mins for the last ½hr. Therefore samples are collected for a total of 3hours at T0, T15, T30, T45, T60, T75, T90, T105, T120, T135, T150 and T180mins. No
See also
  Status Clinical Trial Phase
Recruiting NCT03380221 - Effects of Fresh Watermelon Consumption on Satiety and Cardiometabolic Health N/A
Completed NCT03293693 - Intake of Beta-glucan and Postprandial Regulation of Blood Glucose Metabolism in Healthy Subjects N/A
Completed NCT01999504 - Gut Hormone Response After Paleolithic-type Meals N/A
Completed NCT02379312 - Comparison of the Satiety Effect of a Very Low Energy Foam With Normal Energy Foams N/A
Completed NCT04075448 - The Acute Effect of a Walnut Intervention on Cognitive Performance, Brain Activation, and Serum Markers of Inflammation in Young Adults N/A
Active, not recruiting NCT03306927 - Effect of Peas in Chili on Blood Glucose and Appetite Control N/A
Active, not recruiting NCT03306706 - Effect of Peas in Muffins on Blood Glucose and Appetite Control N/A
Completed NCT00889993 - Satiety Response After Mixed Fiber Doses N/A
Completed NCT03490851 - The Effect of a Breakfast Meal Containing Oat β-glucan on Food Intake at a Subsequent Meal in Normal-weight and Overweight Subjects N/A
Completed NCT04862208 - Breakfast Consumption and Energy Balance in Active Adult Males N/A
Completed NCT04601025 - The Effect of Different Types of Plant-Based Fiber in a Protein-Containing Meal During Satiety and Hunger States N/A
Completed NCT02500069 - Location Specific Differences in Intestinal Brake Activation N/A
Completed NCT03648112 - Effects of Beta-glucan From Barley and Oats on Glucose and Lipid Metabolism, and Satiety N/A
Recruiting NCT04917913 - Efficacy of a Digestive Enzyme Blend N/A
Completed NCT03128684 - The Effects of Lentil-containing Food Products on Satiety and Food Intake N/A
Completed NCT03637829 - Effect of Morning Snack on Cognitive Performance in Adults N/A
Completed NCT03658681 - Effect of Fat Quality on Glycemic Regulation and Gut Microbiota After a Short-time Intervention in Healthy Individuals N/A
Recruiting NCT03957928 - Effects of Fresh Mango Pulp Consumption on Satiety and Cardiometabolic Health N/A
Active, not recruiting NCT02480582 - The Impact of Snacks Which Vary Nutritionally in Their Satiating Potential on Measures of Appetite Control N/A
Completed NCT02482545 - Breakfast Meal Replacement N/A